Bionoid Pharma, Inc. (BINP) Stock

About Bionoid Pharma, Inc.

Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.

Bionoid Pharma, Inc. is headquartered in US.

Bionoid Pharma, Inc. (BINP) stock trades at $0.03 with a market capitalization of $1.62M. The stock is valued at a negative price-to-earnings (P/E) ratio of -3.53, reflecting a net loss over the last twelve months, price-to-book of 0.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.02 and $0.45, and currently trades 93.3% below its 52-week high.

On profitability, Bionoid Pharma, Inc. generates a return on equity (ROE) of -11.65% (negative, reflecting a net loss), return on capital employed of -11.61%.

Official website: bionoidinc.com